Durvalumab,Carboplatin,Paclitaxel,Cisplatin,Gemcitabine,Pemetrexed
Astrazeneca
['lung']
phase iii trial led by our dr. john heymach shows pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy improved event-free survival and pathologic complete response for_x000d_non-small cell lung cancer. #aacr2023
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789